Exbio — Research products — Antibodies — CD and related antigens — Anti-Hu CD95 Purified Low Endotoxin

Anti-Hu CD95 Purified Low Endotoxin

Regulatory status

RUO

Antigen

CD95

Clone

EOS9.1

Format

Purified Low Endotoxin

Reactivity

Human

Application

FC (QC tested), FUNC

Variant

0.1 mg

12-753-C100

In stock

130.00 USD

Variant

0.1 mg

11-261-C100

In stock

130.00 USD

Contact distributor

Product details

Description

Images

References

Isotype

Mouse IgM kappa

Specificity

The mouse monoclonal antibody EOS9.1 recognizes an extracellular epitope of CD95 (Fas/APO-1), a 46 kDa glycoprotein of the tumour necrosis factor/nerve growth factor (TNF/NGF) receptor superfamily, expressed on a variety of normal and neoplastic cells.

Application

FC (QC tested), FUNC

Application details

Functional application: In vitro induction of apoptosis.
Flow cytometry: Recommended dilution: 2-6 µg/ml.

Reactivity

Human

Immunogen

P815 cells transfected with human CD95

Concentration

1 mg/ml

Preparation

Purified by sequential steps of physicochemical fractionation (differential precipitation and solid-phase chromatography methods).

Formulation

Phosphate buffered saline (PBS), pH 7.4

Storage and handling

Store at 2-8°C. Do not freeze.

The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.

Other names

FAS1, APT1, APO-1, FASTM, ALPS1A, TNFRSF6

Antigen description

CD95 (Fas, APO-1), a 46 kDa transmembrane glycoprotein, is a cell death receptor of the TNFR superfamily. Stimulation of CD95 results in aggregation of its intracellular death domains, formation of the death-inducing signaling complex (DISC) and activation of caspases. In type I cells caspase 3 is activated by high amounts of caspase 8 generated at the DISC, in type II cells low concentration of caspase 8 activates pathway leading to the release of cytochrome c from mitochondria and activation of caspase 3 by cytochom c. Besides its roles in induction of apoptosis, Fas also triggers pro-inflammatory cytokine responses.

Entrez Gene ID 355

UniProt ID P25445

Separation of anti-CD95 (EOS9.1) antibody stimulated Jurkat cells (24 hours, 4 µg/ml, red-filled) from nonstimulated Jurkat cells (black-dashed) in flow cytometry analysis of Jurkat cellular suspension stained using ApoFlowEx kit (ED7044).

Separation of anti-CD95 (EOS9.1) antibody stimulated CEM cells (24 hours, 1 µg/ml, red-filled) from nonstimulated CEM cells (black-dashed) in flow cytometry analysis CEM cell suspension stained using ApoFlowEx kit (ED7044).

General references:

Brumatti G, Yon M, Castro FA, Bueno-da-Silva AE, Jacysyn JF, Brunner T, Amarante-Mendes GP: Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide. Exp Cell Res. 2008 Feb 1;314(3):554-63.
PubMed

Guo Z, Zhang M, Tang H, Cao X: Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood. 2005 Sep 15;106(6):2033-41.
PubMed

Park DR, Thomsen AR, Frevert CW, Pham U, Skerrett SJ, Kiener PA, Liles WC: Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol. 2003 Jun 15;170(12):6209-16.
PubMed

Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998 Mar 16;17(6):1675-87.
PubMed

Product specific references:

Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK: Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol. 2003 Feb;5(2):118-25.
PubMed

Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, Cutler C, Ho VT, Alyea EP, Antin JH, Soiffer RJ, Ritz J: Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest. 2010 May;120(5):1479-93
PubMed

Kasper HU, Konze E, Kern M, Stippel DL: CD95 and TNFα-induced apoptosis in liver metastases of colorectal carcinoma. In Vivo. 2010 Sep-Oct;24(5):653-7.
PubMed

Conejo-Garcia JR, Benencia F, Courreges MC, Gimotty PA, Khang E, Buckanovich RJ, Frauwirth KA, Zhang L, Katsaros D, Thompson CB, Levine B, Coukos G: Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells. Cancer Res. 2004 Mar 15;64(6):2175-82.
PubMed

Variant

0.1 mg

12-753-C100

In stock

130.00 USD

Variant

0.1 mg

11-261-C100

In stock

130.00 USD

Contact distributor

Datasheet download